Macrophages as susceptible targets for HIV infection, persistent viral reservoirs in tissue, and key immunoregulatory cells that control levels of virus replication and extent of disease.
about
Induction of interleukin-10 by human immunodeficiency virus type 1 and its gp120 protein in human monocytes/macrophagesInduction of interleukin-12 (IL-12) by recombinant glycoprotein gp120 of human immunodeficiency virus type 1 in human monocytes/macrophages: requirement of gamma interferon for IL-12 secretionActivities of masked 2',3'-dideoxynucleoside monophosphate derivatives against human immunodeficiency virus in resting macrophagesMacrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humansCharacterization of the follicular dendritic cell reservoir of human immunodeficiency virus type 1.Molecular characterization of biologically diverse envelope variants of human immunodeficiency virus type 1 derived from an individual.SIVsm Tat, Rev, and Nef1: functional characteristics of r-GV internalization on isotypes, cytokines, and intracellular degradation.Proteomic analysis of HIV-infected macrophagesRegulation of human immunodeficiency virus type 1 infection, beta-chemokine production, and CCR5 expression in CD40L-stimulated macrophages: immune control of viral entry.Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity.Endosomal trafficking of nanoformulated antiretroviral therapy facilitates drug particle carriage and HIV clearance.Amino acid deletions are introduced into the V2 region of gp120 during independent pathogenic simian immunodeficiency virus/HIV chimeric virus (SHIV) infections of rhesus monkeys generating variants that are macrophage tropic.HIV reservoirs in vivo and new strategies for possible eradication of HIV from the reservoir sites.Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains.The majority of freshly sorted simian immunodeficiency virus (SIV)-specific CD8(+) T cells cannot suppress viral replication in SIV-infected macrophages.Global HIV/AIDS Clinical and Translational PharmacologyInfectious HIV-1 assembles in late endosomes in primary macrophagesPersistent infection of rabbits with bovine immunodeficiency-like virus.Nerve growth factor is an autocrine factor essential for the survival of macrophages infected with HIVHIV‑1 downregulates the expression and phosphorylation of receptor tyrosine kinase by targeting the NF‑κB pathway.The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells.The LD78beta isoform of MIP-1alpha is the most potent CC-chemokine in inhibiting CCR5-dependent human immunodeficiency virus type 1 replication in human macrophages.Induction of beta interferon by human immunodeficiency virus type 1 and its gp120 protein in human monocytes-macrophages: role of beta interferon in restriction of virus replication.Transactivation of human immunodeficiency virus type 1 long terminal repeats by cell surface tumor necrosis factor alpha.Human immunodeficiency virus type 1: resistance to nucleoside analogues and replicative capacity in primary human macrophages.Direct effect of human immunodeficiency virus protease inhibitors on neutrophil function and apoptosis via calpain inhibition.Splenic Damage during SIV Infection: Role of T-Cell Depletion and Macrophage Polarization and Infection.Immunological dysfunction in HIV-1-infected individuals caused by impairment of adenosine deaminase-induced costimulation of T-cell activation.
P2860
Q24676612-CDE4289C-82B5-407E-A0B8-056645B5524BQ24682710-5630C4ED-86B2-475F-AD8E-FDD140BC498DQ28343822-392E52EF-8E66-45D3-9B6A-3B848C3A7350Q28345408-CFFCE220-1E35-4E16-B97A-A9B0AE0B6DE3Q33326800-427CB73D-D551-47B0-8D42-12A789A9A524Q33379671-6CC494F2-F5DE-4D38-BEDE-BD2D7EE24D1AQ33636080-2916CE8C-DA20-44D4-B3C6-7680DCB91EA9Q33770687-061DFE5F-768F-4165-AB86-4CED2A6E1016Q33839665-475DD764-EB71-49CC-8803-6D41434CA1F1Q33847458-E4A199E0-3443-4BFA-AD4C-CC1CA996C52EQ34059457-A4908A4E-4352-499C-8A18-A0544CE8A870Q34161633-2A54B4C2-31EA-4CD6-8325-3A89556270B8Q35557244-7D1A0AF0-660C-4252-9689-533F560B9D66Q35611425-EB8AC780-565C-4A26-A0E9-40B21A377487Q35868086-5BA75843-A56F-4CA9-9868-EC163100BF89Q36125023-B9E661F7-1451-4BC2-83F9-64FC2AC73EE7Q36323044-73FD1385-2DC3-4197-AD45-3EC6C9EEF85FQ36699115-EDE7C069-1D9D-49AC-8FC3-AB5504B1BD57Q36706107-3AA6AE40-6EE8-4591-A794-0D6897149E37Q37190782-05BEC20B-2BBC-4E61-905F-9E40A995C0E1Q38777355-C86ECF04-26BF-4C4B-95A0-BDE32F1BE0DDQ38877913-FBC98C7D-56C7-4725-8BDA-FFDC3E5B7C56Q40039812-C6B10651-AFFD-43F6-9459-33B18F004C58Q40115290-42B8C276-B3FD-4034-AD72-D70C14A4FEFDQ40173457-3C85C6BB-046A-4FAC-B4BC-5E223E11CDCFQ41829112-A914994B-BFC3-4C10-A979-0BF2A646D8EDQ41873622-7E3B4F26-A87D-4379-891C-EAE7090CEA72Q43196418-60C62837-A04F-44F9-94C1-3BB73E55970E
P2860
Macrophages as susceptible targets for HIV infection, persistent viral reservoirs in tissue, and key immunoregulatory cells that control levels of virus replication and extent of disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Macrophages as susceptible tar ...... ication and extent of disease.
@en
Macrophages as susceptible tar ...... ication and extent of disease.
@nl
type
label
Macrophages as susceptible tar ...... ication and extent of disease.
@en
Macrophages as susceptible tar ...... ication and extent of disease.
@nl
prefLabel
Macrophages as susceptible tar ...... ication and extent of disease.
@en
Macrophages as susceptible tar ...... ication and extent of disease.
@nl
P2093
P356
P1476
Macrophages as susceptible tar ...... ication and extent of disease.
@en
P2093
Gendelman HE
Meltzer MS
Nakamura M
P304
P356
10.1089/AID.1990.6.967
P577
1990-08-01T00:00:00Z